Allergan Patent For Zymar Not Valid: Apotex
In a patent dispute over Allergan Inc.'s antibiotic Zymar, which is used to treat bacterial infections in the eye, Apotex Inc. is arguing that its proposed generic version would not infringe...To view the full article, register now.
Already a subscriber? Click here to view full article